Kenya All Set for COVID-19 Clinical Trials

Researchers are seeking approval to conduct the trials to determine if Remdesivir, an antiretroviral drug approved by the U.S. Food and Drug Administration for emergency treatment of COVID-19, as well as the anti-malaria drug hydroxychloroquine, and Lopinavir/ritonavir can effectively treat COVID-19 patients in Kenya.

Dr Loice Achieng Ombajo at the Kenyatta National Hospital Infectious Disease Unit. She is the principal investigator in the study.


AllAfrica publishes around 700 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.